Monopar Therapeutics Inc.
MNPR
$77.19
$1.251.64%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 169.81% | -2.39% | -9.40% | 900.19% | -15.43% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -16.59% | -5.02% | 563.62% | 59.07% | -18.69% |
| Total Current Assets | 168.09% | -2.41% | -8.65% | 893.31% | -15.46% |
|
|
|||||
| Total Current Assets | 168.09% | -2.41% | -8.65% | 893.31% | -15.46% |
| Net Property, Plant & Equipment | -9.73% | 1,198.90% | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 167.70% | -2.21% | -8.63% | 893.31% | -15.46% |
|
|
|||||
| Total Accounts Payable | 63.67% | 3.90% | -33.82% | 100.76% | 3.07% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.99% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 62.19% | 6.14% | -71.60% | 367.92% | 3.07% |
|
|
|||||
| Total Current Liabilities | 62.19% | 6.14% | -71.60% | 367.92% | 3.07% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.82% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 58.62% | 11.53% | -71.60% | 367.92% | 3.07% |
|
|
|||||
| Common Stock & APIC | 69.82% | 0.73% | 0.95% | 87.32% | 0.26% |
| Retained Earnings | -4.25% | -3.13% | -3.46% | -16.84% | -2.05% |
| Treasury Stock & Other | -84.92% | 455.96% | -160.56% | 427.27% | -232.53% |
| Total Common Equity | 171.17% | -2.60% | -2.62% | 1,012.57% | -18.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 171.17% | -2.60% | -2.62% | 1,012.57% | -18.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 171.17% | -2.60% | -2.62% | 1,012.57% | -18.78% |
|
|
|||||